If you have a certain type of lung cancer, your doctor may prescribe Tagrisso. It’s used to treat specific kinds of non-small cell lung cancer in adults. For more details about Tagrisso’s uses, see ...
How Well Does Tagrisso Work for Lung Cancer? The FDA approved Tagrisso based on clinical trials for EGFR-mutated lung cancer in several different scenarios. Tagrisso was studied in people who had lung ...
SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib or datopotamab deruxtecan-dlnk to TAGRISSO upon disease progression demonstrates strong clinical activity Susan Galbraith, ...
Tagrisso, with chemotherapy, reduced the risk of disease progression or death by 38% by investigator assessment vs. Tagrisso monotherapy. Median progression-free survival was 25.5 months in Tagrisso ...
Tagrisso combined with chemotherapy improved overall survival in EGFR-mutated NSCLC patients, including those with poor prognostic factors, compared to Tagrisso alone. The FLAURA2 trial demonstrated ...
SAVANNAH and ORCHARD Phase II trials show the addition of Orpathys or Datroway to Tagrisso upon disease progression demonstrates strong clinical activity New study results presented at the European ...
On Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy for the 1st-line treatment of adult patients with ...
In LAURA Phase III trial, Tagrisso continues to demonstrate improved overall survival trend in unresectable, Stage III setting SAVANNAH and ORCHARD Phase II trials show the addition of Orpathys or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback